Skip to main content

Debevoise & Plimpton has represented Japan’s Sawai Pharmaceutical in a $1.05 billion to purchase the generic-drug unit of Minnesota-based Upsher-Smith Laboratories, which turned to U.S. firm Lindquist & Vennum for advice. 

Osaka-based Sawai is buying Upsher-Smith from Acova, a business owned by the Evenstad family. After the deal, which is expected to close in June, Upsher-Smith’s president Rusty Field will continue to run the company and its business management team will stay in place. 

According to Reuters, Osaka-based Sawai said it is making the deal – its first overseas acquisition – to boost its presence in the U.S., the world’s largest market for generic medicines. The move also comes amid sluggish growth in Japan’s overall generic-drugs market.  

Founded in 1919, Upsher-Smith has a diverse portfolio of more than 30 pharmaceutical products that treat various conditions, including epilepsy.

The Debevoise team was led by partner Andrew Bab, with support from partners Gary Friedman, Sean Hecker, Elizabeth Pagel Serebransky and Scott Selinger.

Related Articles

Deals

Khaitan, JSA, Hogan Lovells guide $515 mln Waaree IPO

by Nimitt Dixit |

Khaitan & Co has advised Waaree Energies, India's largest manufacturer and exporter of solar modules, on its $515 million initial public offering, with JSA Advocates & Solicitors and Hogan Lovells guiding the bookrunning lead managers.

Deals

CAM, Khaitan guide Adani-backed Renew Exim’s $380 mln ITD acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas has advised Adani Group's Dubai-based firm Renew Exim DMCC on its acquisition of a 46.64 percent stake in ITD Cementation India for around $380 million from Italian-Thai Development Public Company, who was represented by Khaitan & Co.

Deals

CAM, AZB, SAM, Latham advise on landmark $1.3 bln Swiggy IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas is advising SoftBank-backed Indian food and grocery delivery giant Swiggy on its much-anticipated initial public offering worth $1.3 billion, with AZB & Partners and Latham & Watkins advising the bookrunning lead managers.